Brief: Vaxart Q2 Net Income USD -22.55 Million
03/08/2023 21:01
Aug 03 (Reuters) - Vaxart Q2 basic EPS USD -0.16. * Q2 operating income USD -23.053 million * Q2 operating expenses USD 24.411 million * Q2 pretax profit USD -22.531 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts